Law Firm Investigates Option Care Health Merger Deal
Monteverde & Associates is probing Option Care Health over a potential merger, raising shareholder rights concerns.
A New York-based class action law firm has launched an investigation into Option Care Health, Inc., the Nasdaq-listed home and alternate-site infusion therapy company, according to a disclosure issued in October 2026. Monteverde & Associates PC, which bills itself as a mergers-and-acquisitions-focused class action firm, is examining whether shareholders' interests are being adequately protected in connection with a potential transaction involving the company.
Attorney Juan Monteverde is leading the inquiry. The firm has been recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report and states it has recovered millions of dollars on behalf of investors in prior cases. Such investigations typically precede formal litigation if attorneys conclude that a deal's terms, disclosures, or negotiation process may have shortchanged shareholders.
Read more Retail Investing Platforms Top 41 Million Accounts in Record Quarter →
Shareholder investigations of this kind are common when publicly traded companies announce mergers or acquisitions. Law firms scrutinize the sale price, the board's approval process, and the adequacy of proxy disclosures to determine whether investors received fair value. If deficiencies are found, attorneys may seek to enjoin a transaction or pursue damages after a deal closes.
Option Care Health trades on the Nasdaq under the ticker OPCH. Shareholders who hold or recently held shares in the company and wish to learn more about their legal rights are the primary audience for the firm's alert. The investigation is at a preliminary stage, and no formal complaint had been filed at the time of the announcement.
Continue reading at All Financial Services & Investing.
